These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6661358)
21. Studies on the time course of dithranol-induced inflammation by quantification of alkaline phosphatase. Timmerman MG; Mier PD; van de Kerkhof PC Acta Derm Venereol; 1990; 70(1):66-9. PubMed ID: 1967879 [TBL] [Abstract][Full Text] [Related]
22. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation. Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292 [TBL] [Abstract][Full Text] [Related]
23. Irritation and staining by dithranol (anthralin) and related compounds: II. Structure-activity relationships among 10-meso-substituted acyl analogues. Mustakallio KK Acta Derm Venereol; 1980; 60(2):169-71. PubMed ID: 6155030 [TBL] [Abstract][Full Text] [Related]
24. The effect of clobetasol-17-propionate and crude coal tar on dithranol-induced inflammation. A clinical and biochemical study. van de Kerkhof PC; Timmerman MG Acta Derm Venereol; 1990; 70(5):434-7. PubMed ID: 1980981 [TBL] [Abstract][Full Text] [Related]
25. Levels of prostaglandins and arachidonic acid in UV-B irradiated human skin before and after topical application of benzyl-2,5-diacetoxybenzoate, a salicylic acid derivative. Barr RM; Black AK; Mallet AI; Greaves MW Prostaglandins Leukot Med; 1982 Jul; 9(1):35-43. PubMed ID: 6813876 [TBL] [Abstract][Full Text] [Related]
26. Contact allergy to dithranol. de Groot AC; Nater JP Contact Dermatitis; 1981 Jan; 7(1):5-8. PubMed ID: 7249629 [TBL] [Abstract][Full Text] [Related]
27. [Suppression of cignolin-induced erythema by tar]. Schulze HJ Z Hautkr; 1984 May; 59(10):659-62. PubMed ID: 6741205 [No Abstract] [Full Text] [Related]
28. Lack of upregulation of epidermal fatty acid binding protein in dithranol induced irritation. Kucharekova M; Vissers WH; Schalkwijk JJ; van de Kerkhof PC; van der Valk PG Eur J Dermatol; 2003; 13(3):254-7. PubMed ID: 12804984 [TBL] [Abstract][Full Text] [Related]
29. The effect of indomethacin on anthralin inflammation. Ramsay B; Rice N; Lawrence C Br J Dermatol; 1992 Mar; 126(3):262-5. PubMed ID: 1554602 [TBL] [Abstract][Full Text] [Related]
30. Topical treatment of psoriasis with dithranol. Farber EM Acta Derm Venereol Suppl (Stockh); 1984; 112():11-6. PubMed ID: 6596820 [No Abstract] [Full Text] [Related]
31. Irritant potential of dithranol. Haustein UF; Lohrisch I Dermatologica; 1986; 173(6):288-93. PubMed ID: 3817240 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes. Gehring W; Ghyczy M; Gloor M; Scheer T; Röding J Arzneimittelforschung; 1992 Jul; 42(7):983-5. PubMed ID: 1418067 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of anthralin inflammation. I. Dissociation of response to clobetasol and indomethacin. Lawrence CM; Shuster S Br J Dermatol; 1985 Jul; 113(1):107-15. PubMed ID: 4015967 [TBL] [Abstract][Full Text] [Related]
34. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone). Mustakallio KK; Brandt H Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285 [TBL] [Abstract][Full Text] [Related]